Bill Title: To direct the Comptroller General of the United States to conduct a study to assess the key regulatory barriers that impede the expansion or siting of new pharmaceutical manufacturing facilities in the United States, and for other purposes.

Spectrum: Partisan Bill (Republican 2-0)

Status: (Introduced) 2025-02-18 - Referred to the House Committee on Energy and Commerce. [HB1405 Detail]

Text: Not Available

---

Voting Records

Chamber	Vote	Date	Yea	Nay	NV	Abs	Total	Result	Source	View
No roll call record information currently on file.

States not producing parsable votes may be available as images in Supplemental Documents.

Social Comments on US HB1405